Endolinksp. k.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-01-15
Limited partner contribution
90,000.00 PLN
Registered address
ul. Piotrkowska 46/8u, 90-265 Łódź, Poland

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 91 days late).

  • 202514/07/2026
  • 202414/07/2025
  • 202313/07/2024
  • 202213/07/2023
  • 202114/10/2022
  • 202016/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 767.36kMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD -1.29kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 766.20kMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 1.20mMedianUSD 608.93kAverageUSD 11.85m

Partners

Partners
Endolink Sp. z o.o.
Katarzyna Potargowicz Ciochage 49

Manner of representation

The general partner is authorised to submit and receive declarations of will on behalf of the company independently: ENDOLINK spółka z ograniczoną odpowiedzialnością, represented by the management board thereof in accordance with the manner of representation of that company, i.e. the President of the Management Board is authorised to represent the company and sign obligations on behalf of the company independently, and in the case of a multi-member management board, a member of the management board acting jointly with a commercial proxy. The President of the one-person management board of ENDOLINK spółka z ograniczoną odpowiedzialnością is PIOTR CIOCH.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2016-06-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

11 public aid cases recorded, with a total value of $58,815.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$18,629
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$504
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$559

Competitors

Name
TDFS.A.
Mercantsp. z o.o.
Medgazsp. z o.o.
Celltrion Polandsp. z o.o.
Rhinegene Polandsp. z o.o.
Mediationsp. z o.o.
Alfafarmasp. z o.o.
Goldfarmexsp. z o.o.
Orthoactivesp. z o.o.
CanpolandS.A.

Change history

DateEvent
2024-09-16Address change
2019-01-23Address change
2017-08-24Address change
2015-01-15Entered in the register

FAQ

Last updated: 2026-07-17